Literature DB >> 16683963

Anticonvulsants in bipolar disorder.

Charles L Bowden1, Nancy U Karren.   

Abstract

OBJECTIVE: To review the literature on the effectiveness of anticonvulsant drugs in the management of bipolar disorder.
METHODS: A selective review of the literature.
RESULTS: Valproate is an effective drug, alone or in combination, for mania, but has limited benefit in bipolar depression. Although valproate is widely used in maintenance therapy of bipolar disorder, and secondary analyses suggest benefit, in the largest randomised maintenance trial there was only a trend favouring valproate. Lamotrigine has benefit in bipolar depression and maintenance, but not in mania. Carbamazepine is effective in mania. Other anticonvulsant drugs have been tried in mania, but with mixed results.
CONCLUSIONS: Valproate, lamotrigine and carbamazepine have a valuable place in the management of bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16683963     DOI: 10.1080/j.1440-1614.2006.01815.x

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  9 in total

1.  Lamotrigine inhibits basal and Na+-stimulated, but not Ca2+-stimulated, release of corticotropin-releasing hormone from the rat hypothalamus.

Authors:  Giuseppe Tringali; Jean Michel Aubry; Pierluigi Navarra; Giacomo Pozzoli
Journal:  Psychopharmacology (Berl)       Date:  2006-09-01       Impact factor: 4.530

2.  Effect of valproic acid through regulation of NMDA receptor-ERK signaling in sleep deprivation rats.

Authors:  Hae Jeong Park; Won Sub Kang; Jong Woo Paik; Jong Woo Kim
Journal:  J Mol Neurosci       Date:  2011-11-19       Impact factor: 3.444

Review 3.  Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans.

Authors:  Mireille Basselin; Epolia Ramadan; Stanley I Rapoport
Journal:  Brain Res Bull       Date:  2011-12-09       Impact factor: 4.077

4.  Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder.

Authors:  Pieter Stolk; Patrick C Souverein; Ingeborg Wilting; Hubert G M Leufkens; Donald F Klein; Stanley I Rapoport; Eibert R Heerdink
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2009-11-25       Impact factor: 4.006

5.  Chronic administration of valproic acid reduces brain NMDA signaling via arachidonic acid in unanesthetized rats.

Authors:  Mireille Basselin; Lisa Chang; Mei Chen; Jane M Bell; Stanley I Rapoport
Journal:  Neurochem Res       Date:  2008-05-07       Impact factor: 3.996

6.  Chronic carbamazepine administration reduces N-methyl-D-aspartate receptor-initiated signaling via arachidonic acid in rat brain.

Authors:  Mireille Basselin; Nelly E Villacreses; Mei Chen; Jane M Bell; Stanley I Rapoport
Journal:  Biol Psychiatry       Date:  2007-07-12       Impact factor: 13.382

Review 7.  Psychosis: atypical limbic epilepsy versus limbic hyperexcitability with onset at puberty?

Authors:  Frank R Sharp; Robert L Hendren
Journal:  Epilepsy Behav       Date:  2007-04-06       Impact factor: 2.937

8.  The role of lamotrigine in the management of bipolar disorder.

Authors:  Felicity Ng; Karen Hallam; Nellie Lucas; Michael Berk
Journal:  Neuropsychiatr Dis Treat       Date:  2007-08       Impact factor: 2.570

9.  Valproic Acid Reduces Vasospasm through Modulation of Akt Phosphorylation and Attenuates Neuronal Apoptosis in Subarachnoid Hemorrhage Rats.

Authors:  Chieh-Hsin Wu; Yi-Cheng Tsai; Tai-Hsin Tsai; Keng-Liang Kuo; Yu-Feng Su; Chih-Hui Chang; Chih-Lung Lin
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.